CD68 and Alzheimer disease: Similarly, increased CD68 and a trend toward increased HLA-DR and decreased TM119 and P2RY12 has been shown in both the temporal pole and visual cortex in AD patients compared to resilient and control donors, demonstrating that these changes already become apparent in the visual cortex before the presence of AD pathology [53].